|Spotlight on Relapsed/Refractory Follicular Lymphoma
James O. Armitage, MD; and Reid W. Merryman, MD
|Release Date: December 09, 2022
Expiration Date: December 09, 2023
In this activity, Dr. Merryman will address the expanding landscape in the treatment of follicular lymphoma and, along with Dr. Armitage, they will discuss the current standard of care. Dr. Merryman will provide a comprehensive overview of the emerging data in the relapsed setting and discuss the current placement of those agents in the future treatment paradigm with a discussion of potential impact to patient care and outcomes.Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
|Begin, Earn CreditView Only, No Credit|